Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.

A Mark Fendrick,Matthew Davis,Diana Brixner,Manish Mittal,Philip Mease,David T Rubin,Harry Liu

doi:10.18553/jmcp.2021.20560

Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.

A Mark Fendrick, Matthew Davis + Show 5 more

Open Access

https://doi.org/10.18553/jmcp.2021.20560

Copy DOI

Journal: Journal of Managed Care & Specialty Pharmacy	Publication Date: Apr 12, 2021
Citations: 8

Affiliation: University of Michigan–Ann Arbor, University of Utah, AbbVie (United States), Providence College, Swedish Medical Center, University of Washington, University of Chicago, RAND Corporation

#Patient Support Programs #Hospital Visits + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BACKGROUND: Patient support programs (PSPs) improve medication-taking behavior in the first 12 months of treatment for patients with immune-mediated diseases, but it is unknown if these benefits ar...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Managed Care & Specialty Pharmacy

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.